KAHF Biotech is on its way to open a new avenue for treatment and prevention of cancer metastasis. The main focus of KAHF Biotech is on cancer cell plasticity and metastasis.

We Will Bring Preventive and Therapeutic Approaches Against Cancer Metastasis

Cellular Plasticity

Cellular plasticity is characterized by the ability of cells to convert between different (intermediate) cellular states by inducing epithelial-to-mesenchymal transition (EMT), as well as mesenchymal-to-epithelial transition (MET)

Orthotopic Model

We are able to develop Pancreatic Ductal Adenocarcinoma (PDAC) orthotopic models where genetically engineered PDAC cell lines or patient-derived cells implement into the pancreas or animal.

Cancer Metastasis

Metastatic tumor cells acquire certain features, allowing them to survive and grow out within a distant hostile microenvironment. All these characteristics can be controlled by unlocking cellular plasticity.

KAHF Biotech

KAHF Biotech is on its way

Collaboration

We are eager to collaborate with Angel Investors and Venture Capital.

Team Work

OUR MISSION

At KAHF Biotechnology, we are driven by a simple, yet profound truth: cancer patients deserve more than the silence of being told, “There’s nothing more we can do.” Our name is rooted in the timeless story of KAHF-a story of resilience, refuge, and unwavering faith in the face of great adversity. Just as the youths sought shelter in a cave and were granted protection and time, we strive to offer a refuge for patients and families navigating the storm of cancer.

We believe that every scientific breakthrough is a form of divine timing-that healing comes through both persistence and trust in a higher plan. Our work is more than just medicine; it is a mission to bring hope, strength, and life-saving innovation to those who need it most.

At KAHF Biotechnology, we are on a relentless mission to Chase, Capture, and Eliminate metastatic cancer cells. We chase new frontiers in cancer therapy, targeting metastatic disease with cutting-edge research and innovation. We capture cancer with pinpoint accuracy, ensuring our therapies reach the heart of the disease. And, most importantly, we eliminate it-bringing life-saving solutions to those who have run out of options.

Motto: Chase, Capture, Eliminate

KAHF Biotech is in preliminary stage of development. The mission of company is to open a new avenue for treatment and prevention of cancer metastasis. The company’s focus is on Cancer Metastasis Prevention and Elimination.

Mission Statement

Our mission is to seek and establish the foundation to become the industry leader in metastatic cancer drug development, offering refuge to patients battling metastatic tumor cells. We are committed to providing innovative therapies that not only fight cancer but also provide a sanctuary of hope, healing, and strength for those in their most challenging moments.

Vision

Our vision is to revolutionize metastatic cancer treatment by developing impactful, effective, and affordable therapies that are accessible to cancer patients worldwide. We aim to overcome the current challenges of metastatic disease and ensure that groundbreaking treatments reach those who need them most, no matter where they are.

 

OUR SKILLS
Development
Design
Marketing
Consulting
MSN
MSN

Muhammad Sadeqi Nezhad, Founder and CEO of KAHF Biotech

KAHF Biotech

0
HOURS OF WORK
0
FINISHED WORKS
0
CLIENTS
0
SOCIAL FOLLOWERS

Email address:

Work 1: muhammad_sadeqinezhad@kahfbiotech.com

Work 2: labmsn9@gmail.com